The rise and rise of big data promises to drive increasingly imaginative scientific computing approaches, 
says Felix Grant
Beth Harlen reports on the strides being made within the UK climate modelling community
Our ability to digitise the world around us now readily outstrips our ability to process the data we generate. 
Rob Baxter reports
John Barr offers his take on the future of cloud computing and HPC
A level of debate surrounds the question of how and when we might reach exascale computing. Industry experts share their views on the subject
Andrew Jones explains why, 
when it comes to high-performance computing, science/dollar is not 
the same as Flops/dollar
Are informatics solutions keeping up with trends in pharma? Beth Harlen speaks to industry figures
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
